US$ 20.45
glp-1 agonists tirzepatide Stopping Receptor Agonists… Why and How to Plan an “Exit Strategy” for Your Patients Bumps and humps in the
Description
Discover proper techniques for current injectable GLP-1 medications and what to know about future transdermal delivery systems.

New research suggests that switching to a maintenance dose of GLP-1 medication could help lock in weight loss.

Chronic diseases such as obesity and diabetes, cardiovascular and inflammatory bowel diseases (IBD) share common features in their pathology

In recent years, there has been an increase in the morbidity, disability rate,and mortality due to obesity, making ...
Learn about the latest science behind GLP-1 weight loss drugs, the nutritional needs of GLP-1 users and what this means for future innovation in food and beverage.

Latest review of the Tirzepatide dual receptor agonist GLP-1/GIP, summarizing five clinical trials in type 2-diabetic subjects.